IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

CURE POINT LLP

LLPIN : ACW-2886|ROC: RoC-Mumbai-IActive
Last Updated On : 19-03-2026
LLPINACW-2886
LLP NameCURE POINT LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Mumbai-I
Date of Incorporation13-03-2026
Registered AddressWeWork Oberoi CommerzII Flr 20 Oberoi Garden City Goregaon East Mumbai Goregaon East Maharashtra India 400063
Email IDcompliance@truenorth.co.in
Total Obligation of Contribution2,000
Main division of business activity to be carried out in India21
Description of main divisionMANUFACTURE OF PHARMACEUTICALS, MEDICINAL CHEMICAL AND BOTANICAL PRODUCTS
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
00025669RAJAGOPALAN SANTHANAM13-03-2026
02849420SATISH CHANDER SUBBANNA13-03-2026
CURE POINT LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai-I, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 13-03-2026 and last updated on 19-03-2026. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, CURE POINT LLP has a total contribution of INR 2,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is WeWork Oberoi CommerzII Flr 20 Oberoi Garden City Goregaon East Mumbai Goregaon East Maharashtra India 400063. Correspondence or inquiries may be sent to the official email address, compliance@truenorth.co.in.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.